Jenburkt Pharmaceuticals Ltd — Insider Trading, 23-03-2026: Insider Trading / SAST

Jenburkt Pharmaceuticals has closed its trading window for insiders, designated persons, and their relatives, effective April 1. This move anticipates the upcoming release of the audited financial results for the quarter and financial year ending March 31. The trading window will reopen 48 hours after these key financial results are made public. Investors should note the company will announce the Board Meeting schedule to consider these results separately.